Search alternatives:
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
point decrease » point increase (Expand Search)
Showing 201 - 220 results of 3,300 for search '(( significant barrier decrease ) OR ( significant ((small decrease) OR (point decrease)) ))', query time: 0.50s Refine Results
  1. 201
    The importance of entry criteria from the point of view of the SD method ‐ combinations B1 –B5.

    The importance of entry criteria from the point of view of the SD method ‐ combinations B1 –B5. by Roman Vavrek (13200141)

    Published 2024
    Save to List
    Saved in:
  2. 202
    The importance of entry criteria from the point of view of the SD method ‐ combinations C1 –C10.

    The importance of entry criteria from the point of view of the SD method ‐ combinations C1 –C10. by Roman Vavrek (13200141)

    Published 2024
    Save to List
    Saved in:
  3. 203
    Point load strength apparatus: (a) before modification; (b) after modification.

    Point load strength apparatus: (a) before modification; (b) after modification. by Hong Zhang (25820)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 204
    Effect of 1.25(OH)<sub>2</sub>D<sub>3</sub> treatment on proteinuria at different time points after the induction of glomerulonephritis.

    Effect of 1.25(OH)<sub>2</sub>D<sub>3</sub> treatment on proteinuria at different time points after the induction of glomerulonephritis. by Jian-feng Li (8667645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 205
    miR-184 does not downregulate target pSJ and TCJ mRNA levels but changes Nrv2 expression.

    miR-184 does not downregulate target pSJ and TCJ mRNA levels but changes Nrv2 expression. by Sravya Paluri (5475260)

    Published 2025
    Save to List
    Saved in:
  6. 206
    The Laboratory Animal Flow Diagram.

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 207
    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).

    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 208
    General procedure for the synthesis of B.

    General procedure for the synthesis of B. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 209
    The trends of gene expression in the metabolism of triglycerides in liver tissue.

    The trends of gene expression in the metabolism of triglycerides in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 210
    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.

    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 211
    The trends of cholesterol metabolism-related gene expression in liver tissue.

    The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 212
    <sup>1</sup>H NMR spectra for kylo-0603.

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 213
    Kylo-0603’s EC50 & tissue levels.

    Kylo-0603’s EC50 & tissue levels. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 214
    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.

    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 215
    The trends in the expression of inflammation-related genes in liver tissue.

    The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 216
    The Fibrosis scoring by Sirius Red staining and SHG/TPEF.

    The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 217
    Effects of Kylo-0603 on body weight, organ weight, and body fat content.

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 218
    The trends in the expression of fibrosis-related genes in liver tissue.

    The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 219
    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.

    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 220
    Plasma cholesterol and LDL-C levels.

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: